[HTML][HTML] Intravenous levothyroxine for unstable brain-dead heart donors

R Dhar, GF Marklin, WD Klinkenberg… - … England Journal of …, 2023 - Mass Medical Soc
Background Hemodynamic instability and myocardial dysfunction are major factors
preventing the transplantation of hearts from organ donors after brain death. Intravenous …

The role of thyroid hormone administration in potential organ donors

A Salim, P Vassiliu, GC Velmahos, J Sava… - Archives of …, 2001 - jamanetwork.com
Hypothesis Levothyroxine sodium therapy should be used in brain-dead potential organ
donors to reverse hemodynamic instability and to prevent cardiovascular collapse, leading …

Aggressive pharmacologic donor management results in more transplanted organs1

JD Rosendale, HM Kauffman, MA McBride… - …, 2003 - journals.lww.com
Background. Brain death results in adverse pathophysiologic effects in many cadaveric
donors, resulting in cardiovascular instability and poor organ perfusion. Hormonal …

Hormonal resuscitation yields more transplanted hearts, with improved early function1

JD Rosendale, HM Kauffman, MA McBride… - …, 2003 - journals.lww.com
Background. Brain death results in cardiovascular instability and poor organ perfusion in
many brain-dead donors. Hormonal resuscitation stabilizes certain brain-dead donors and is …

Using thyroid hormone in brain‐dead donors to maximize the number of organs available for transplantation

A Salim, M Martin, C Brown, K Inaba… - Clinical …, 2007 - Wiley Online Library
The aggressive management of brain‐dead (cadaveric) organ donors has been shown to
increase organs available for transplantation. Some centers use hormone therapy with …

A systematic review and meta-analysis of clinical trials of thyroid hormone administration to brain dead potential organ donors

PS Macdonald, A Aneman, D Bhonagiri… - Critical care …, 2012 - journals.lww.com
Objectives: To review all published clinical studies of thyroid hormone administration to
brain-dead potential organ donors. Methods: A search of PubMed using multiple search …

Thyroid hormone therapy in the management of 63,593 brain-dead organ donors: a retrospective analysis

D Novitzky, Z Mi, Q Sun, JF Collins… - Transplantation, 2014 - journals.lww.com
Background Hormonal therapy to the brain-dead potential organ donor can include thyroid
hormone (triiodothyronine [T 3] or levothyroxine [T 4]), corticosteroids, antidiuretic hormone …

Reversal of donor myocardial dysfunction by triiodothyronine replacement therapy.

V Jeevanandam, B Todd, T Regillo… - The Journal of Heart …, 1994 - europepmc.org
Triiodothyronine deficiency after brain death can result in progressive deterioration of
cardiac function in potential organ donors. We report on the use of triiodothyronine …

[HTML][HTML] Eficiency of triiodothyronine treatment on organ donor hemodynamic management and adenine nucleotide concentration

A Pérez-Blanco, J Caturla-Such… - Intensive care …, 2005 - Springer
Objective We compared hemodynamic values, oxygen utilization, and adenine nucleotide
concentration in the extracted organs of brain-dead donors treated with triiodothyronine vs …

Improved cardiac allograft function following triiodothyronine therapy to both donor and recipient

D Novitzky, DKC Cooper, JS Chaffin, AE Greer… - …, 1990 - journals.lww.com
Brain death is associated with neuroendocrine changes, in particular with a significant
reduction of plasma-free triiodothyronine (T3) that results in impaired aerobic metabolism …